ARTICLES BY THIS AUTHOR
- 10/9/2019
MinuteClinic expands telehealth offering to Oregon, Washington
MinuteClinic video visits are now available in 32 states. - 10/9/2019
FDA approves new Rituxan indication
Roche's Rituxan now is the first and only FDA approved treatment for pediatric patients 2 years of age and older living with granulomatosis with polyangiitis or microscopic polyangiitis. - 10/9/2019
Glenmark gets tentative FDA nod for generic Tecfidera
Tecfidera capsules, 120 mg and 240 mg had a market value of approximately $3.7 billion for the 12 months ended in August 2019. - 10/9/2019
Amneal launches generic Invega
Paliperidone extended-release tablets had a market value of approximately $373 million for the 12 months ended July 31. - 10/7/2019
California law enables pharmacists to dispense PrEP and PEP without a prescription
SB 159 authorizes pharmacists to prescribe PrEP and PEP to patient without a physician prescription and prohibits insurance companies from requiring patients to obtain prior authorization before using their insurance benefits to obtain PrEP or PEP. - 10/7/2019
Bartell’s, P&G support cancer research during Breast Cancer Awareness month
During October, Bartell Drugs, Proctor & Gamble and Fred Hutchinson Cancer Research Center are teaming up for breast cancer research, awareness, and support. - 10/7/2019
MerckManuals.com focuses on recognizing depression during Mental Illness Awareness Week
MerckManuals.com, an online medical reference, is highlighting expert information on depression and how to recognize the disorder. - 10/7/2019
MinuteClinic expands telehealth offering to Michigan, Pennsylvania and South Carolina
MinuteClinic Video Visits are now available in 32 states. - 10/6/2019
Pfenex gets FDA nod for potential Forteo generic
Forteo had a global market value of $1.6 billion in 2018. - 10/6/2019
Fresenius Kabi introduces generic Faslodex
Fresenius Kabi developed its fulvestrant injection prefilled syringe to be stable at room temperature, so that it doesn't require refrigeration.